KD Logo

Seelos Therapeutics Inc [SEEL] Insider Activity: An Update for Investors

Seelos Therapeutics Inc’s recently made public that its Chief Financial Officer Golembiewski Michael Joseph acquired Company’s shares for reported $0.1 million on Nov 30 ’23. In the deal valued at $1.21 per share,83,000 shares were bought. As a result of this transaction, Golembiewski Michael Joseph now holds 86,450 shares worth roughly $19019.0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Mehra Raj bought 75,757 shares, generating $99,999 in total proceeds. Upon buying the shares at $1.32, the insider now owns 185,142 shares.

ROTH Capital upgraded its Seelos Therapeutics Inc [SEEL] rating to a Buy from a a Neutral in a research note published on September 27, 2021; the price target was increased to $8 from $2.50. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating. Cantor Fitzgerald began covering SEEL with “an Overweight” recommendation on June 01, 2021. ROTH Capital revised its rating on May 17, 2021. It rated SEEL as “a Neutral” which previously was an “a Buy”.

Price Performance Review of SEEL

On Tuesday, Seelos Therapeutics Inc [NASDAQ:SEEL] saw its stock jump 20.90% to $0.22. Over the last five days, the stock has gained 11.11%. Seelos Therapeutics Inc shares have fallen nearly -97.98% since the year began. Nevertheless, the stocks have fallen -99.90% over the past one year. While a 52-week high of $242.40 was reached on 01/09/24, a 52-week low of $0.18 was recorded on 09/11/24. SMA at 50 days reached $0.3585, while 200 days put it at $4.5618.

Levels Of Support And Resistance For SEEL Stock

The 24-hour chart illustrates a support level at 0.1954, which if violated will result in even more drops to 0.1658. On the upside, there is a resistance level at 0.2522. A further resistance level may holdings at 0.2794. The Relative Strength Index (RSI) on the 14-day chart is 39.51, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0279, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.37%. Stochastics %K at 16.17% indicates the stock is a buying.

How much short interest is there in Seelos Therapeutics Inc?

A steep rise in short interest was recorded in Seelos Therapeutics Inc stocks on 2024-08-30, growing by 0.26 million shares to a total of 0.41 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 0.15 million shares. There was a rise of 64.15%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on March 30, 2021 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $15 price target.

Most Popular